Alzheimer's: Medicines help manage symptoms and slow decline
WEBJul 10, 2024 · Alzheimer's disease gradually damages and destroys nerve cells in the brain. This results in a decline in memory, reasoning and other thinking skills. Medicines that treat symptoms do not stop the loss of nerve cells. Instead, they're designed to help healthy nerve cells work as well as possible even though cells will continue to be lost.
Medications for Memory Loss | Alzheimer's Association
WEBAlthough current medications cannot cure Alzheimer's, three U.S. Food and Drug Administration (FDA)-approved treatments address the underlying biology. Other medications may help lessen symptoms, such as memory loss and confusion.
Medications for memory loss, cognition, dementia, and more
WEBApr 4, 2024 · Medications, such as cholinesterase inhibitors and glutamate regulators, can treat memory loss. They can help manage a person’s memory loss symptoms and modify the progression of their...
Alzheimer’s Disease Medication - WebMD
WEBJul 3, 2024 · Medications for dementia include cholinesterase inhibitors like donepezil and rivastigmine to slow symptom progression, and memantine for moderate to severe cases, aiding memory and daily...
Memory loss: When to seek help - Mayo Clinic
WEBApr 3, 2024 · You may need blood tests, brain-imaging scans and other tests that can help pinpoint reversible causes of memory loss and dementia-like symptoms. You might be referred to a specialist in diagnosing dementia or memory conditions, such as a neurologist, psychiatrist, psychologist or geriatrician.
Alzheimer's treatments: What's on the horizon? - Mayo Clinic
WEBJul 10, 2024 · Current Alzheimer's treatments temporarily improve symptoms of memory loss and problems with thinking and reasoning. These Alzheimer's treatments boost the performance of chemicals in the brain that carry information from one brain cell to another.
Dementia Medications: Donepezil, Memantine & More - Healthline
WEBMar 8, 2019 · Cholinesterase inhibitors work by increasing acetylcholine, a chemical in your brain that aids in memory and judgment. Increasing the amount of acetylcholine in your brain may delay...
Lecanemab, the New Alzheimer’s Treatment: 3 Things To Know
WEBJul 24, 2023 · The Food and Drug Administration (FDA) recently granted full approval to a new Alzheimer’s treatment called lecanemab, which has been shown to moderately slow cognitive and functional decline in early-stage cases of the disease. Alzheimer’s disease is a progressive disorder that damages and destroys nerve cells in the brain.
Dementia medicine: Medications and other treatments - Medical News Today
WEBMay 19, 2023 · In 2021, a brand-name form of aducanumab called Aduhelm became the first treatment targeting one of the hallmark brain changes of Alzheimer’s disease to gain FDA approval. Aducanumab works in a...
A new Alzheimer's drug has been approved. But should you take it?
WEBJul 15, 2021 · Aducanumab (brand name Aduhelm) is a monoclonal antibody engineered in a laboratory to stick to the amyloid molecule that forms plaques in the brains of people with Alzheimer's. Most researchers believe that the plaques form first and damage brain cells, causing tau tangles to form inside them, killing the cells.